Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields

Area of Science:

• Oncology
• Nanomedicine
• Cell Biology

Background:

• Cancer resistance to conventional therapies necessitates novel treatment strategies.
• Lysosomal cell death pathways are emerging as promising alternatives.
• Targeted nanotechnologies offer potential for selective cancer cell destruction.

Purpose of the Study:

• To investigate the potential of iron oxide magnetic nanoparticles (MNPs) to induce lysosomal death pathways in cancer cells.
• To evaluate the efficacy of MNPs targeted to the epidermal growth factor receptor (EGFR) in combination with an alternating magnetic field (AMF).

Main Methods:

• Utilized EGFR-targeted iron oxide magnetic nanoparticles (MNPs).
• Applied an alternating magnetic field (AMF) to induce lysosomal membrane permeabilization (LMP).
• Assessed reactive oxygen species (ROS) production, cathepsin B activity, and tumor cell viability.

Main Results:

• MNPs selectively induced LMP in EGFR-overexpressing cancer cells under AMF.
• LMP correlated with increased ROS production and reduced tumor cell viability.
• Confocal microscopy confirmed elevated cytosolic cathepsin B activity.

Conclusions:

• Remotely triggering lysosomal death pathways in cancer cells is feasible using targeted MNPs and AMFs.
• This nanomedicine approach shows promise for overcoming cancer treatment resistance.
• Further research into MNPs for targeted cancer therapy is warranted.